Daily Market Reports | Oct 07 2025
An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities.
In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Australian Broker Call *Extra* Edition, featuring additional sources of research and insights on ASX-listed stocks, also enlarging the number of stocks that make up the FNArena universe.
One key difference is the *Extra* Edition will not be updated daily, but merely "regularly" depending on availability of suitable quality content. As such, the *Extra* Edition tries to build a bridge between daily updates via the Australian Broker Call Report and ad hoc news stories, that are not always timely for investors hungry for the next information update.
Investors using the *Extra* Edition as a source of input for their own share market research should thus take into account that information after publication may not be up to date, or yet awaiting another update by FNArena's team of journalists.
Similar to The Australian Broker Call Report, this *Extra* Edition includes concise but limited reviews of research recently published by Stockbrokers and other experts, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end of this Report.
The Australian Broker Call *Extra* Edition is a summary that has been prepared independently of the sources identified. Readers will check the full text of the recommendations and consult a Licenced Advisor before making any investment decision.
The copyright of this Report is owned by the publisher. Readers will not copy, forward or disseminate this Report to any other person. For more vital information about the sources included, see the bottom of this Report.
COMPANIES DISCUSSED IN THIS ISSUE
Click on a symbol for fast access.
The number next to the symbol represents the number of brokers covering it for this report -(if more than 1)
ABB ACL AQZ ASG AVH BVS CKF COH CSL CUV DTL ELD EQT FPH GNC IPD IRE JAN M7T MGH MVF NCK PLT PME PNC PNI PNV RDY RFF RHC RIC RMD RWL SDR SHV SKS SOM TLX TNE VYS
ABB AUSSIE BROADBAND LIMITED
Telecommunication - Overnight Price: $5.87
Canaccord Genuity rates ((ABB)) as Buy (1) -
Following Canaccord Genuity's acquisition of Wilsons, Cameron Bell will take over coverage of Aussie Broadband.
Buy. Target Price $6.85.
This report was published on October 3, 2025.
Target price is $6.85 Current Price is $5.87 Difference: $0.98
If ABB meets the Canaccord Genuity target it will return approximately 17% (excluding dividends, fees and charges).
Current consensus price target is $5.95, suggesting upside of 1.4%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 6.30 cents and EPS of 18.10 cents.
At the last closing share price the estimated dividend yield is 1.07%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 32.43.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 18.8, implying annual growth of 68.0%.
Current consensus DPS estimate is 6.4, implying a prospective dividend yield of 1.1%.
Current consensus EPS estimate suggests the PER is 31.2.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 10.60 cents and EPS of 26.50 cents.
At the last closing share price the estimated dividend yield is 1.81%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 22.15.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 25.4, implying annual growth of 35.1%.
Current consensus DPS estimate is 8.1, implying a prospective dividend yield of 1.4%.
Current consensus EPS estimate suggests the PER is 23.1.
Market Sentiment: 0.9
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
ACL AUSTRALIAN CLINICAL LABS LIMITED
Healthcare services - Overnight Price: $2.50
Canaccord Genuity rates ((ACL)) as Buy (1) -
Following Canaccord Genuity's acquisition of Wilsons, Australian Clinical Labs continues to be covered by Shane Storey.
Buy. Target Price $3.85.
This report was published on October 3, 2025.
Target price is $3.85 Current Price is $2.50 Difference: $1.35
If ACL meets the Canaccord Genuity target it will return approximately 54% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 11.40 cents and EPS of 19.00 cents.
At the last closing share price the estimated dividend yield is 4.56%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 13.16.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 13.20 cents and EPS of 22.00 cents.
At the last closing share price the estimated dividend yield is 5.28%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 11.36.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
AQZ ALLIANCE AVIATION SERVICES LIMITED
Transportation & Logistics - Overnight Price: $2.16
Canaccord Genuity rates ((AQZ)) as Buy (1) -
Following Canaccord Genuity's acquisition of Wilsons, Alliance Aviation Services continues to be covered by James Ferrier.
Buy. Target Price $2.58.
This report was published on October 3, 2025.
Target price is $2.58 Current Price is $2.16 Difference: $0.42
If AQZ meets the Canaccord Genuity target it will return approximately 19% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 12.30 cents and EPS of 35.10 cents.
At the last closing share price the estimated dividend yield is 5.69%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 6.15.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 16.60 cents and EPS of 33.30 cents.
At the last closing share price the estimated dividend yield is 7.69%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 6.49.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
The full story is for FNArena subscribers only. To read the full story plus enjoy a free two-week trial to our service SIGN UP HERE
If you already had your free trial, why not join as a paying subscriber? CLICK HERE